QQQ   304.37 (-1.78%)
AAPL   151.92 (-1.77%)
MSFT   266.73 (-0.31%)
META   183.43 (-4.27%)
GOOGL   99.37 (-7.68%)
AMZN   100.05 (-2.02%)
TSLA   201.29 (+2.28%)
NVDA   222.05 (+0.14%)
NIO   10.65 (-2.47%)
BABA   105.11 (-0.37%)
AMD   84.69 (-1.42%)
T   19.16 (-0.47%)
F   13.42 (-0.22%)
MU   60.25 (-3.03%)
CGC   2.74 (-2.84%)
GE   81.96 (-0.18%)
DIS   111.78 (+0.13%)
AMC   5.72 (-7.44%)
PFE   43.98 (+0.89%)
PYPL   79.72 (-4.22%)
NFLX   366.83 (+1.07%)
QQQ   304.37 (-1.78%)
AAPL   151.92 (-1.77%)
MSFT   266.73 (-0.31%)
META   183.43 (-4.27%)
GOOGL   99.37 (-7.68%)
AMZN   100.05 (-2.02%)
TSLA   201.29 (+2.28%)
NVDA   222.05 (+0.14%)
NIO   10.65 (-2.47%)
BABA   105.11 (-0.37%)
AMD   84.69 (-1.42%)
T   19.16 (-0.47%)
F   13.42 (-0.22%)
MU   60.25 (-3.03%)
CGC   2.74 (-2.84%)
GE   81.96 (-0.18%)
DIS   111.78 (+0.13%)
AMC   5.72 (-7.44%)
PFE   43.98 (+0.89%)
PYPL   79.72 (-4.22%)
NFLX   366.83 (+1.07%)
QQQ   304.37 (-1.78%)
AAPL   151.92 (-1.77%)
MSFT   266.73 (-0.31%)
META   183.43 (-4.27%)
GOOGL   99.37 (-7.68%)
AMZN   100.05 (-2.02%)
TSLA   201.29 (+2.28%)
NVDA   222.05 (+0.14%)
NIO   10.65 (-2.47%)
BABA   105.11 (-0.37%)
AMD   84.69 (-1.42%)
T   19.16 (-0.47%)
F   13.42 (-0.22%)
MU   60.25 (-3.03%)
CGC   2.74 (-2.84%)
GE   81.96 (-0.18%)
DIS   111.78 (+0.13%)
AMC   5.72 (-7.44%)
PFE   43.98 (+0.89%)
PYPL   79.72 (-4.22%)
NFLX   366.83 (+1.07%)
QQQ   304.37 (-1.78%)
AAPL   151.92 (-1.77%)
MSFT   266.73 (-0.31%)
META   183.43 (-4.27%)
GOOGL   99.37 (-7.68%)
AMZN   100.05 (-2.02%)
TSLA   201.29 (+2.28%)
NVDA   222.05 (+0.14%)
NIO   10.65 (-2.47%)
BABA   105.11 (-0.37%)
AMD   84.69 (-1.42%)
T   19.16 (-0.47%)
F   13.42 (-0.22%)
MU   60.25 (-3.03%)
CGC   2.74 (-2.84%)
GE   81.96 (-0.18%)
DIS   111.78 (+0.13%)
AMC   5.72 (-7.44%)
PFE   43.98 (+0.89%)
PYPL   79.72 (-4.22%)
NFLX   366.83 (+1.07%)
NYSE:NHI

National Health Investors - NHI Stock Forecast, Price & News

$57.26
+0.21 (+0.37%)
(As of 02/8/2023 12:00 AM ET)
Add
Compare
Today's Range
$56.74
$57.50
50-Day Range
$52.11
$59.60
52-Week Range
$50.22
$67.16
Volume
262,847 shs
Average Volume
217,948 shs
Market Capitalization
$2.48 billion
P/E Ratio
36.47
Dividend Yield
6.22%
Price Target
$61.25

National Health Investors MarketRank™ Forecast

Analyst Rating
Hold
2.25 Rating Score
Upside/​Downside
7.0% Upside
$61.25 Price Target
Short Interest
Healthy
2.41% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-2.59
Upright™ Environmental Score
News Sentiment
0.52mentions of National Health Investors in the last 14 days
Based on 11 Articles This Week
Insider Trading
Acquiring Shares
$56,600 Bought Last Quarter
Proj. Earnings Growth
-0.22%
From $4.53 to $4.52 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.20 out of 5 stars

Finance Sector

463rd out of 857 stocks

Real Estate Investment Trusts Industry

108th out of 190 stocks

NHI stock logo

About National Health Investors (NYSE:NHI) Stock

National Health Investors, Inc. engages in the sale-leaseback, joint-venture, mortgage, and mezzanine financing of senior housing and medical investments. Its portfolio includes lease, mortgage and other note investments in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities, specialty hospitals, and medical office buildings. The company was founded by W. Andrew Adams in 1991 and is headquartered in Murfreesboro, TN.

Receive NHI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for National Health Investors and its competitors with MarketBeat's FREE daily newsletter.

NHI Stock News Headlines

6%-Yielding National Health Investors: No Pain, No Gain
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
The One Ticker Retirement Plan Over the Shoulder Demo Now Available
Market Wizard Larry Benedict crushed the market in 2022. But he hasn’t done it with a “traditional” method… For a limited time, he’s sharing a free over-the-shoulder “demo” of his strategy in action. It takes less than 10 seconds…
NHI Announces Third Quarter 2022 Results
Douglas Emmett (DEI) Matches Q3 FFO Estimates
NHI Breaks Above 7% Yield Territory
Synairgen encouraged by NIH Covid study data
National Health Investors (NYSE: NHI)
See More Headlines
Receive NHI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for National Health Investors and its competitors with MarketBeat's FREE daily newsletter.

NHI Company Calendar

Last Earnings
5/09/2022
Ex-Dividend for 1/27 Dividend
12/29/2022
Dividend Payable
1/27/2023
Today
2/08/2023
Next Earnings (Confirmed)
2/21/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Real estate investment trusts
Sub-Industry
Specialized REITs
Sector
Finance
CUSIP
63633D10
Employees
19
Year Founded
1991

Price Target and Rating

Average Stock Price Forecast
$61.25
High Stock Price Forecast
$64.00
Low Stock Price Forecast
$58.00
Forecasted Upside/Downside
+7.0%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
4 Analysts

Profitability

Net Income
$111.80 million
Pretax Margin
25.41%

Debt

Sales & Book Value

Annual Sales
$298.71 million
Cash Flow
$4.25 per share
Book Value
$33.08 per share

Miscellaneous

Free Float
40,239,000
Market Cap
$2.48 billion
Optionable
Optionable
Beta
0.91

Social Links


Key Executives

  • D. Eric Mendelsohn
    President, Chief Executive Officer & Director
  • John L. Spaid
    Chief Financial Officer & Executive VP-Finance
  • Kevin C. Pascoe
    Chief Investment Officer
  • Kristin Sallee Gaines
    Chief Credit Officer
  • Michelle Kelly
    Senior Vice President-Investments













NHI Stock - Frequently Asked Questions

Should I buy or sell National Health Investors stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for National Health Investors in the last twelve months. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" NHI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NHI, but not buy additional shares or sell existing shares.
View NHI analyst ratings
or view top-rated stocks.

What is National Health Investors' stock price forecast for 2023?

4 Wall Street research analysts have issued twelve-month price objectives for National Health Investors' stock. Their NHI share price forecasts range from $58.00 to $64.00. On average, they expect the company's stock price to reach $61.25 in the next twelve months. This suggests a possible upside of 6.7% from the stock's current price.
View analysts price targets for NHI
or view top-rated stocks among Wall Street analysts.

How have NHI shares performed in 2023?

National Health Investors' stock was trading at $52.22 at the beginning of 2023. Since then, NHI stock has increased by 10.0% and is now trading at $57.43.
View the best growth stocks for 2023 here
.

When is National Health Investors' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 21st 2023.
View our NHI earnings forecast
.

How can I listen to National Health Investors' earnings call?

National Health Investors will be holding an earnings conference call on Wednesday, February 22nd at 12:00 PM Eastern. Interested parties can register for or listen to the call using this link.

How were National Health Investors' earnings last quarter?

National Health Investors, Inc. (NYSE:NHI) issued its quarterly earnings data on Monday, May, 9th. The real estate investment trust reported $0.18 earnings per share for the quarter, missing analysts' consensus estimates of $0.63 by $0.45. The real estate investment trust had revenue of $71.33 million for the quarter, compared to analyst estimates of $73.06 million. National Health Investors had a trailing twelve-month return on equity of 4.96% and a net margin of 25.62%. The company's quarterly revenue was down 11.8% compared to the same quarter last year. During the same period last year, the company posted $1.24 earnings per share.

How often does National Health Investors pay dividends? What is the dividend yield for National Health Investors?

National Health Investors announced a quarterly dividend on Tuesday, November 8th. Shareholders of record on Friday, December 30th will be paid a dividend of $0.90 per share on Friday, January 27th. This represents a $3.60 annualized dividend and a yield of 6.27%. The ex-dividend date is Thursday, December 29th.
Read our dividend analysis for NHI
.

Is National Health Investors a good dividend stock?

National Health Investors (NYSE:NHI) pays an annual dividend of $3.60 per share and currently has a dividend yield of 6.22%. NHI has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 229.30%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, NHI will have a dividend payout ratio of 79.65% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for NHI.

What guidance has National Health Investors issued on next quarter's earnings?

National Health Investors updated its FY 2022 earnings guidance on Thursday, December, 8th. The company provided earnings per share guidance of $3.86-$3.92 for the period. The company issued revenue guidance of -.

What other stocks do shareholders of National Health Investors own?

Based on aggregate information from My MarketBeat watchlists, some companies that other National Health Investors investors own include AT&T (T), AbbVie (ABBV), Verizon Communications (VZ), Cisco Systems (CSCO), Annaly Capital Management (NLY), JPMorgan Chase & Co. (JPM), Simon Property Group (SPG), Energy Transfer (ET), QUALCOMM (QCOM) and Broadcom (AVGO).

What is National Health Investors' stock symbol?

National Health Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "NHI."

Who are National Health Investors' major shareholders?

National Health Investors' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Lasalle Investment Management Securities LLC (0.73%), Sumitomo Mitsui Trust Holdings Inc. (0.65%), Swiss National Bank (0.25%), Asset Management One Co. Ltd. (0.24%), Lee Danner & Bass Inc. (0.21%) and Nepsis Inc. (0.12%). Insiders that own company stock include D Eric Mendelsohn, Kevin Carlton Pascoe, Robert G Adams, Robert T Webb and W Andrew Adams.
View institutional ownership trends
.

How do I buy shares of National Health Investors?

Shares of NHI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is National Health Investors' stock price today?

One share of NHI stock can currently be purchased for approximately $57.43.

How much money does National Health Investors make?

National Health Investors (NYSE:NHI) has a market capitalization of $2.49 billion and generates $298.71 million in revenue each year. The real estate investment trust earns $111.80 million in net income (profit) each year or $1.57 on an earnings per share basis.

How can I contact National Health Investors?

National Health Investors' mailing address is 222 ROBERT ROSE DRIVE, MURFREESBORO TN, 37129. The official website for the company is www.nhireit.com. The real estate investment trust can be reached via phone at (615) 890-9100, via email at investorrelations@nhireit.com, or via fax at 615-225-3030.

This page (NYSE:NHI) was last updated on 2/8/2023 by MarketBeat.com Staff